• Nenhum resultado encontrado

Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.

N/A
N/A
Protected

Academic year: 2017

Share "Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation."

Copied!
16
0
0

Texto

Loading

Imagem

Table 1. Amino acid changes in HA and NA sequences of reassortants during generation of A/Anhui/01/2013-CDC-LV7A.
Fig 1. The growth characteristic of MDV, A/Anhui/1/2013 and 6:2 LAIV reassortants CDC-LV7A, A (H7N9)RG-LV1 and A(H7N9)RG-LV2 in eggs
Table 2. Cycle threshold (C t ) values (±Std. Dev) of CDC-LV7A RNA corresponding to 10 5 EID 50 /per reaction.
Table 3. Amino acid changes in A/Anhui/01/2013(H7N9)-CDC-LV7A before and after passaging in eggs.
+3

Referências

Documentos relacionados

The development, in the coming decades, of more effective vaccines against the influenza virus, of vaccines against other clinically relevant viruses such as RSV, adenovirus

Novel influenza A(H7N9) virus linked to human disease in China, April 2013.. Analysis of the clinical characteristics and treatment of two patients with avian influenza

The objectives of this study were to determine the incidence of infection by respiratory viruses (RSV; parainfluenza viruses 1, 2 and 3; influenza A and B viruses; and adenovirus)

Re- combinant, chimeric live, attenuated vaccine (Chimerivax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes

It is generally accepted that human influenza viruses bind glycans containing sialic acid linked a 2–6 to the next sugar, that avian influenza viruses bind glycans containing the a

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children.. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M,

Objective: Detection of the eight most common respiratory viruses: Human respiratory syncytial virus (HRSV), influenza virus A and B (IA and IB), parainfluenza viruses 1, 2 and

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy